Literature DB >> 2265613

Synergistic trans-activation of the human C-reactive protein promoter by transcription factor HNF-1 binding at two distinct sites.

C Toniatti1, A Demartis, P Monaci, A Nicosia, G Ciliberto.   

Abstract

The promoter region of the human C-reactive protein (CRP) gene comprises two distinct regions (APREs, for Acute Phase Responsive Elements) each one containing information necessary and sufficient for liver specific and IL-6 inducible expression in human hepatoma Hep3B cells. In this paper we show that both APREs contain a low affinity binding site for the liver specific transcription factor HNF-1/LF-B1. The two sites are separated by approximately 80 bp. Mutations in either of the two sites abolish inducible expression. The same effect is specifically obtained in cotransfection competition experiments when the human albumin HNF-1 site is used as competitor. However, HNF-1 is not the intranuclear mediator of IL-6 because synthetic promoters formed by multimerized copies of different HNF-1 binding sites are not transcriptionally activated by this cytokine. An expression vector encoding full length HNF-1 is capable of trans-activating transcription from the wild-type CRP promoter but not from mutants which have lost the ability to bind HNF-1. Moreover, the level of trans-activation observed with the natural promoter containing both HNF-1 binding sites is far greater than the level of mutated variants containing only one of the two sites. This result strongly suggests that two HNF-1 molecules bound simultaneously to sites distant from each other can act synergistically to activate gene expression.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2265613      PMCID: PMC552239          DOI: 10.1002/j.1460-2075.1990.tb07897.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  49 in total

Review 1.  Modularity in promoters and enhancers.

Authors:  W S Dynan
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

Review 2.  Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins.

Authors:  P J Mitchell; R Tjian
Journal:  Science       Date:  1989-07-28       Impact factor: 47.728

Review 3.  Transcriptional repression of eukaryotic promoters.

Authors:  M Levine; J L Manley
Journal:  Cell       Date:  1989-11-03       Impact factor: 41.582

4.  pEMBL: a new family of single-stranded plasmids for sequencing DNA.

Authors:  L Dente; R Cortese
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

5.  The liver-specific transcription factor LF-B1 contains a highly diverged homeobox DNA binding domain.

Authors:  M Frain; G Swart; P Monaci; A Nicosia; S Stämpfli; R Frank; R Cortese
Journal:  Cell       Date:  1989-10-06       Impact factor: 41.582

6.  Determinants of rat albumin promoter tissue specificity analyzed by an improved transient expression system.

Authors:  J M Heard; P Herbomel; M O Ott; A Mottura-Rollier; M Weiss; M Yaniv
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

7.  GAL4 activates gene expression in mammalian cells.

Authors:  H Kakidani; M Ptashne
Journal:  Cell       Date:  1988-01-29       Impact factor: 41.582

8.  Cooperative DNA binding of the yeast transcriptional activator GAL4.

Authors:  E Giniger; M Ptashne
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

9.  Interleukin 6 induces a liver-specific nuclear protein that binds to the promoter of acute-phase genes.

Authors:  V Poli; R Cortese
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

10.  Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6.

Authors:  U Ganter; R Arcone; C Toniatti; G Morrone; G Ciliberto
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

View more
  48 in total

1.  Regulation of basal and induced expression of C-reactive protein through an overlapping element for OCT-1 and NF-kappaB on the proximal promoter.

Authors:  Bhavya Voleti; Alok Agrawal
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

2.  Compilation of vertebrate-encoded transcription factors.

Authors:  S Faisst; S Meyer
Journal:  Nucleic Acids Res       Date:  1992-01-11       Impact factor: 16.971

Review 3.  Bringing genome-wide association findings into clinical use.

Authors:  Teri A Manolio
Journal:  Nat Rev Genet       Date:  2013-07-09       Impact factor: 53.242

4.  N-carbamylglutamate enhancement of ureagenesis leads to discovery of a novel deleterious mutation in a newly defined enhancer of the NAGS gene and to effective therapy.

Authors:  Sandra K Heibel; Nicholas Ah Mew; Ljubica Caldovic; Yevgeny Daikhin; Marc Yudkoff; Mendel Tuchman
Journal:  Hum Mutat       Date:  2011-09-09       Impact factor: 4.878

5.  C-reactive protein levels in hereditary angioedema.

Authors:  Z L M Hofman; A Relan; C E Hack
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

6.  The effect of interleukin-1 on C-reactive protein expression in Hep3B cells is exerted at the transcriptional level.

Authors:  D Zhang; S L Jiang; D Rzewnicki; D Samols; I Kushner
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

7.  Hepatocyte nuclear factor 1 and C/EBP are essential for the activity of the human apolipoprotein B gene second-intron enhancer.

Authors:  A R Brooks; B Levy-Wilson
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

8.  Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.

Authors:  Katharine R Owen; Gaya Thanabalasingham; Timothy J James; Fredrik Karpe; Andrew J Farmer; Mark I McCarthy; Anna L Gloyn
Journal:  Diabetes Care       Date:  2010-08-19       Impact factor: 17.152

9.  Assessing the association of the HNF1A G319S variant with C-reactive protein in Aboriginal Canadians: a population-based epidemiological study.

Authors:  Sylvia H Ley; Robert A Hegele; Philip W Connelly; Stewart B Harris; Mary Mamakeesick; Henian Cao; Joel Gittelsohn; Ravi Retnakaran; Bernard Zinman; Anthony J Hanley
Journal:  Cardiovasc Diabetol       Date:  2010-08-18       Impact factor: 9.951

10.  Trans-dominant inhibition of transcription activator LFB1.

Authors:  A Nicosia; R Tafi; P Monaci
Journal:  Nucleic Acids Res       Date:  1992-10-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.